AVTX Avalo Therapeutics, Inc. Total Asset Value of Company
The success of Avalo Therapeutics, Inc (AVTX) relies on antibody test results, while management strictly controls R&D expenses to maintain adequate reserves. The company is developing targeted immunotherapy methods to combat orphan pathologies. This chart of the market value of total assets, which currently stands at 308.71, highlights risks driven by liquidity shortages and previous failures in new compound trials.
Analytical breakdowns and data insights for company Avalo Therapeutics Inc. (AVTX)
- stock quotes and analyst forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Avalo Therapeutics, Inc|AVTX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Avalo Therapeutics Inc|AVTX - Company Aggregate Debts|Debts to Book Capitalization Avalo Therapeutics Inc|AVTX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Avalo Therapeutics|Interim Coverage Ratio avalotx.com
- net income and valuation multiples indicators:
Fundamental valuation:Avalo Therapeutics, Inc
The resource capitalization of Avalo Therapeutics, Inc (AVTX) determines its ability to withstand market volatility. Patent protection for antibodies and FDA certification costs create significant barriers to entry for competitors within the targeted therapy niche. Monitoring total assets (via ROA) captures the dynamics of fundamental capital, calculated in reverse to assess business scaling. The growth of this indicator confirms an expanding resource base, although investing at the trend's peak increases the risk of overpayment.
Key competitors
Total Business Assets ARGX|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|RIGL - Company Total Assets|ANAB (AnaptysBio, Inc.) - Cumulative Company Assets|ATXS (astriatx.com) - Aggregate Company Assets|ENGN (enGene) - Company Total Assets|Company Total Assets RAPT Therapeutics Inc.|Aggregate Company Assets Aerovate Therapeutics Inc (JBIO)|Aggregate Company Assets ACRS (Aclaris Therapeutics, Inc)|Aggregate Company Assets Kyverna Therapeutics KYTX|tizianalifesciences.com (TLSA) - Company Assets|CABA: Cumulative Company Assets|Aggregate Asset Value VTYX (Ventyx Biosciences Inc.)|THTX (Theratechnologies Inc) - Cumulative Company Assets|ELDN: Aggregate Business Assets|AGEN (Agenus) - Company Total Assets|CLYM: Aggregate Asset Value|Company Total Assets ZURA|ATYR - Company Assets|Aggregate Company Assets Adagene Inc. ADAG|Aggregate Asset Value IMA|Shattuck Therapeutics - Company Total Assets|EQ - Company Total Assets|connectbiopharm.com (CNTB) - Aggregate Company Assets|Total Asset Value of Company IMUX (Immunic)|ATRA (Atara Biotherapeutics, Inc.) - Company Total Assets|Company Assets InflaRx GmbH IFRX|Cumulative Company Assets XFOR (X4 Pharmaceuticals)|Company Total Assets adicetbio.com (ACET)|Celularity - Cumulative Company Assets|Aggregate Business Assets INMB (INmune Bio Inc)|Barinthus Bio - Company Total Assets|Company Total Asset Base Kezar Life Sciences Inc KZR|SABS: Company Total Assets|Cumulative Company Assets akaritx.com|Aggregate Company Assets Enlivex Therapeutics Ltd|Q32 Bio Corp (QTTB) - Company Total Asset Base|Cumulative Company Assets GOVX (GeoVax Labs Inc)|EDSA (Edesa Biotech Corp) - Aggregate Asset Value|Company Total Assets IBIO (iBio, Inc.)|Company Total Asset Base Carisma Therapeutics Inc (CARM)|XTLB - Aggregate Company Assets|BOLT (Bolt Biotherapeutics) - Total Business Assets|HCWB: Company Total Assets|Cumulative Company Assets Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech Inc.) - Company Total Assets|Company Total Assets Aditxt Corp|Cumulative Company Assets GRI (GRI Bio)|Aggregate Company Assets XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences - Cumulative Company Assets|Aggregate Business Assets REVB (Revelation Biosciences Corp)|INDP: Cumulative Company Assets|SCNI (scinai.com) - Total Business Assets|calcimedica.com (CALI) - Aggregate Company Assets|Total Asset Value of Company AFMD (Affimed N.V.)|ALLK (Allakos Inc) - Company Total Assets|HOOK: Aggregate Asset Value|Company Total Assets IGMS|Company Total Assets iteostherapeutics.com (ITOS)|Aggregate Company Assets Ocean Biomedical OCEA|Aggregate Asset Value TCBP|THRD - Aggregate Company Assets